Showing results (241-250 of 470) with videos related to
Sort By:
Pageof 47
Biorxiv : the Preprint Server for Biology|April 8, 2024
OmicsFootPrint: a framework to integrate and interpret multi-omics data using circular images and deep neural networksXiaojia Tang, Naresh Prodduturi, Kevin J Thompson, et al.Breast Cancer Research and Treatment|July 4, 2021
A clinical calculator to predict disease outcomes in women with hormone receptor-positive advanced breast cancer treated with first-line endocrine therapyMei-Yin C Polley, Maura N Dickler, Jason Sinnwell, et al.Nucleic Acids Research|October 24, 2024
OmicsFootPrint: a framework to integrate and interpret multi-omics data using circular images and deep neural networksXiaojia Tang, Naresh Prodduturi, Kevin J Thompson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2007
New approaches to assessing and treating early-stage colon and rectal cancer: summary statement from 2007 Santa Monica ConferenceLee S Rosen, Anton J Bilchik, Robert W Beart, et al.Plos One|February 6, 2013
Endoxifen's molecular mechanisms of action are concentration dependent and different than that of other anti-estrogensJohn R Hawse, Malayannan Subramaniam, Muzaffer Cicek, et al.Endocrinology|October 5, 2017
Skeletal and Uterotrophic Effects of Endoxifen in Female RatsAnne Gingery, Urszula T Iwaniec, Malayannan Subramaniam, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2003
Phase I and pharmacokinetic study of two different schedules of oxaliplatin, irinotecan, Fluorouracil, and leucovorin in patients with solid tumorsMatthew P Goetz, Charles Erlichman, Anthony J Windebank, et al.Cancers|September 9, 2022
Identification of Src Family Kinases as Potential Therapeutic Targets for Chemotherapy-Resistant Triple Negative Breast CancerIshwar N Kohale, Jia Yu, Yongxian Zhuang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 26, 2010
Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancerDaniel J Sargent, Silvia Marsoni, Genevieve Monges, et al.Pharmacogenetics and Genomics|December 15, 2015
Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients: NCCTG N0147 (Alliance)Adam M Lee, Qian Shi, Steven R Alberts, et al.Pageof 47